FOLFIRINOX: from the ACCORD study to 2014
Georgios M Oikonomopoulos1, Konstantinos N Syrigos, Evangelia Skoura
1Second Oncology Department, "St. Savvas" Anticancer Hospital. Athens, Greece. goik77@yahoo.com.
JOP : Journal of the Pancreas
|March 13, 2014
Summary
Modified FOLFIRINOX chemotherapy shows reduced toxicity in pancreatic cancer patients. This approach maintains treatment effectiveness, expanding therapeutic options for a wider patient group.
Area of Science:
- Oncology
- Gastrointestinal Oncology
- Cancer Chemotherapy
Background:
- 5-fluorouracil, leucovorin, irinotecan and oxaliplatin (FOLFIRINOX) is a standard first-line chemotherapy for pancreatic cancer.
- FOLFIRINOX is increasingly used in the neoadjuvant setting for borderline resectable or locally advanced unresectable pancreatic tumors.
- High toxicity of standard FOLFIRINOX limits its use to younger, healthier patients.
Framework:
- This analysis reviews three abstracts from the 2014 ASCO Gastrointestinal Cancers Symposium.
- Focus is on modified FOLFIRINOX regimens, evaluating their toxicity and efficacy.
- The abstracts investigate dose modifications and alternative schedules of FOLFIRINOX.
Implementation:
- Modified FOLFIRINOX regimens were assessed for their safety and effectiveness.
- Dose reductions and adjustments were implemented to mitigate toxicity.
- Clinical outcomes regarding tumor response and patient survival were evaluated.
Implications:
- Modified FOLFIRINOX demonstrates a reduced toxicity profile compared to the standard regimen.
- Treatment effectiveness is preserved despite dose modifications.
- These findings suggest broader applicability of FOLFIRINOX in pancreatic cancer treatment, including in patients with comorbidities.
More Related Videos
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
7.3K
08:12Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
5.1K
Related Concept Videos
02:56Treatment Resistent Cancers
1.1K
1.1K
01:26FDA Approved Drugs: Changes to Approved Drugs
343
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
343
01:11Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
02:56Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
01:16Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248